Diabetes Insipidus: Evaluation

Definition

Pathophysiology & Classification

Step 1: Confirm Polyuria

• Polyuria is defined as >3 L/24 h in adults (or >50 mL/kg/day).
• Exclude osmotic diuresis first: glucose, mannitol, urea (high-protein feeding), post-obstructive diuresis, resolving ATN.
• Initial labs: serum Na, serum osmolality, urine osmolality, urine glucose, BMP.

Step 2: Urine Osmolality — First Branch Point

Step 3: Plasma Copeptin — Modern First-Line Biomarker

Copeptin after hypertonic saline infusion has 97% diagnostic accuracy to distinguish primary polydipsia from central DI, using a cutoff of >4.9 pmol/L. In complete/partial DI, copeptin is ≤4.9 pmol/L; in primary polydipsia, it is >4.9 pmol/L (sensitivity 93.2%, specificity 100%). — Henry's Clinical Diagnosis and Management by Laboratory Methods; Tietz Textbook of Laboratory Medicine

Step 4: Provocative Testing

A. Water Deprivation Test (Classic Method)

1. Baseline: Urine volume (Uvol), urine osmolality (Uosm), plasma osmolality (Posm), plasma Na, weight, BP/pulse (seated + standing)
2. Nothing by mouth throughout; patient must not smoke
3. Measure Uvol, Uosm, Posm, weight, BP/pulse hourly
4. Stop dehydration phase when:
   • Uosm plateau (hourly increase <30 mOsm/kg for 3 consecutive hours), OR
   • Body weight decreases 3–5%, OR
   • Systolic BP drops >20 mmHg
5. Obtain plasma AVP. Then administer 1 µg desmopressin IV/IM (or 5 µg AVP SC)
6. Measure Uosm at 30, 60, and 120 min post-injection

Interpretation

B. Hypertonic Saline Infusion Test (Preferred When Copeptin Available)

• Infuse 3% NaCl for 2 hours to achieve serum Na ≥150 mmol/L
• Measure plasma copeptin at end of infusion
• Copeptin >4.9 pmol/L → primary polydipsia; ≤4.9 pmol/L → central DI
• Advantage: Superior to water deprivation test, especially for partial central DI vs. primary polydipsia; diagnostic accuracy 97%
• Alternative: Arginine infusion test — copeptin <3.5 pmol/L at 60 min confirms DI

C. Desmopressin (DDAVP) Trial

• Administer DDAVP 2 µg IV/SQ
• Marked urine concentration (>50% increase in Uosm) → central DI
• No response → nephrogenic DI
• Caution: Can cause dangerous hyponatremia in primary polydipsia — do not use without confirming concentrated urine during dehydration phase

Step 5: Distinguishing Partial Forms — Nomogram Approach

Step 6: Serum Uric Acid

Step 7: Etiologic Workup (After Type is Established)

Central DI — Causes to Investigate

• MRI pituitary/hypothalamus (T1-weighted, with and without gadolinium): loss of posterior pituitary "bright spot"; look for stalk thickening, mass lesions (germinoma, craniopharyngioma, metastases, LCH, sarcoidosis, IgG4-related disease)
• Trauma/neurosurgical history
• Idiopathic (30–50% of cases, often autoimmune destruction of AVP neurons)
• Genetic: autosomal dominant (signal peptide or neurophysin mutations)

Nephrogenic DI — Causes to Investigate

• AVPR2 mutation (X-linked, >90% of congenital cases): affects V2 receptor; 4–8 per million male births
• AQP2 mutation (<10%): autosomal dominant or recessive

• Drugs: lithium (most common), demeclocycline, amphotericin, methoxyflurane
• Metabolic: hypercalcemia, hypokalemia
• Renal: CKD, obstructive uropathy, pyelonephritis, amyloidosis, multiple myeloma, Sjögren's syndrome, sickle cell anemia

Pitfalls in Evaluation

• Anterior pituitary insufficiency (hypothyroidism, adrenal insufficiency) co-existing with DI can mask polyuria; glucocorticoid replacement may unmask it suddenly
• Medullary washout from chronic polydipsia impairs urine concentration even after DDAVP, mimicking nephrogenic DI — takes days-weeks to recover
• Plasma AVP measurement is unreliable clinically (low accuracy ~38%), hence copeptin is preferred
• Uosm >800 mOsm/kg effectively excludes DI regardless of other findings

Summary Algorithm

Polyuria (>3 L/day)
       ↓
  Urine Osmolality
  ├─ >300 mOsm/kg → Solute diuresis (glucose, urea, etc.)
  ├─ 100–300 mOsm/kg → Mixed; consider partial DI or CKD
  └─ <100–300 mOsm/kg → Water diuresis
         ↓
  Serum Na/Osmolality
  ├─ Low serum Na + low Posm → Primary polydipsia (likely)
  └─ Normal/high serum Na → Measure Plasma Copeptin
         ├─ ≥21.4 pmol/L → Nephrogenic DI (confirmed)
         ├─ <2.6 pmol/L → Complete Central DI (confirmed)
         └─ Intermediate → Water deprivation test OR
                           Hypertonic saline + copeptin
                               ↓
                    DDAVP challenge distinguishes central vs. nephrogenic
         ↓
  Etiologic workup:
  Central DI → MRI brain/pituitary, autoimmune markers
  Nephrogenic DI → Drug history, Ca²⁺, K⁺, AVPR2/AQP2 genetics